Novartis continues to push for neglected disease fund
This article was originally published in Scrip
Executive Summary
Novartisis continuing to discuss its idea of a new global fund for the development of drugs for neglected diseases with a variety of stakeholders. But the worldwide financial crisis has added yet another challenge to this effort.